Cold News and Research

RSS

Clinical trial to evaluate two-drug immunotherapy combination in cancer patients with COVID-19

A unique two-drug immunotherapy combination first evaluated at Roswell Park Comprehensive Cancer Center as an approach for treating some cancers will soon be available to cancer patients with COVID-19 through a clinical trial at Roswell Park.

12 May 2020

Millions stuck at home with no plumbing, kitchen or space to stay safe

In nearly half a million American homes, washing hands to prevent COVID-19 isn't as simple as soaping up and singing "Happy Birthday" twice while scrubbing.

12 May 2020

Odor habituation is driven by important signal filtering process, shows study

Imagine a dog playing in a garden and smelling all of these different flowery smells, and then somewhere in the distance a predator appears, like a fox.

12 May 2020

Collaborative approach is essential to speed up COVID-19 vaccine candidates, say NIH experts

A harmonized and collaborative approach to the clinical testing, scale-up and distribution of candidate vaccines to prevent COVID-19 is essential, scientific leaders write in a perspective published today in Science.

12 May 2020

GCS centers support research to fight against global COVID-19 pandemic

In December 2019, the world learned of a new and deadly pathogen. News coming out of Wuhan, China confirmed public health experts' worst fears--a novel coronavirus appeared to have jumped from animals to humans.

11 May 2020

Novel AI diagnostic can predict COVID-19 based on symptoms

Researchers at King's College London, Massachusetts General Hospital and health science company ZOE have developed an artificial intelligence diagnostic that can predict whether someone is likely to have COVID-19 based on their symptoms.

11 May 2020

Neutralizing SARS-CoV-2 via S protein

A new study published on the preprint server bioRxiv* in May 2020 reports on a method to block severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by destroying its main spike protein, which is responsible for attachment to the host cell membrane.

10 May 2020

Research reinforces the idea of embracing nonantibiotic approaches to treat bacterial infections

As interest in the application of plasma medicine -- the use of low-temperature plasma created by an electrical discharge to address medical problems -- continues to grow, so does the need for research advancements proving its capabilities and potential impacts on the health care industry.

9 May 2020

Researchers develop vaccine for virus associated with type 1 diabetes

According to many observations, certain virus infections may play a part in the autoimmune attack that leads to type 1 diabetes. Researchers at Karolinska Institutet and at the universities of Jyväskylä and Tampere have now produced a vaccine for these viruses in the hope that it could provide protection against the disease. The study is published 6 May 2020 in the scientific journal Science Advances.

8 May 2020

Some foods common in diets of adults with inflammatory bowel disease

American researchers from the Institute for Biomedical Sciences at Georgia State University have found that certain foods such as cheese, cookies, French fries, energy drinks, soda, and other types of junk foods are found more frequently in the diets of adults suffering from inflammatory bowel disease (IBD).

7 May 2020

Study: Skin-to-skin contact shows significant benefits for pre-term babies

A world-first study led by Monash University has demonstrated significant benefits to a premature baby's heart and brain function when held by the parent in skin-to-skin contact.

7 May 2020

The effect of weather on COVID-19 infection rate

Viral epidemics are nothing new in human history. Several viruses circulate freely every year among human beings, causing seasonal outbreaks of disease and death, such as the seasonal flu. A new study published on the preprint server medRxiv* reports that temperature plays a significant role in the growth of the ongoing COVID-19 pandemic.

6 May 2020

Air pollution associated with greater virulence of COVID-19

A new study published on the preprint server medRxiv* in April 2020 provides convincing evidence that air pollution contributes to greater severity of COVID-19. The researchers say, “This suggests the detrimental impact climate change will have on the trajectory of future respiratory epidemics.”

6 May 2020

SARS-CoV-2 in wastewater and rivers

A new study published on the preprint server medRxiv in May 2020 shows that while the virus causing COVID-19 may be present in wastewater and rivers, the biological agent is typically devoid of vitality and unable to cause active infection. This should provide some relief to public health authorities in their quest to contain the virus.

6 May 2020

Interleukin-12 electroporation led to clinical responses in patients with advanced melanoma

Combining intratumoral electroporation of interleukin-12 (IL-12) DNA (tavokinogene telseplasmid, or TAVO) with the immune checkpoint inhibitor pembrolizumab (Keytruda) led to clinical responses in patients with immunologically quiescent advanced melanoma, according to results from a phase II trial.

6 May 2020

Antibiotic Resistance: The Patient Perspective

We discuss the impact of antibiotic-resistant infections on everyday life and the work that is being done to overcome this issue with Antibiotic Research UK.

From Bionow 6 May 2020

Hospitalized smokers six times more likely to quit with combination treatment, study finds

New research led by University of South Australia has found that smokers who receive the medication varenicline tartrate combined with Quitline counseling following a period of hospitalization due to a tobacco-related illness are six times more likely to quit smoking than those who attempt to stop without support.

2 May 2020

Coronaviruses represent a source of pandemic viruses

In a new paper published on the preprint journal bioRxiv in April 2020, researcher T. Konishi argues that the coronavirus family is a constellation of pandemic pathogens, that includes the currently spreading severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

29 Apr 2020

UTHealth experts successfully treat 3-week-old infant with severe COVID-19

In one of the first reported cases of its kind, a 3-week-old infant in critical condition recovered from COVID-19 due to rapid recognition and treatment by physicians from McGovern Medical School at The University of Texas Health Science Center at Houston/

28 Apr 2020

Testing the Structural Studies Of Biopolymers with the CPMAS Cryoprobe

In this interview, Program Manager, Alia Hassan and Application Scientist Barbara Perrone, discuss the game-changing sensitivity enhancements achieved with the CPMAS CryoProbe – all the benefits of the CryoProbe, now available for solids.

From Bruker BioSpin Group 28 Apr 2020